TRV GP III, LLC
Insider CIK 1637299 · NRIX 10% owner · MYOK 10% owner · RVMD 10% owner · GBT 10% owner · VYGR 10% owner · JNCE 10% owner · EDIT 10% owner · FULC 10% owner · NTGN 10% owner · PLRX 10% owner · RLAY 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VYGR Voyager Therapeutics, Inc. | J Other | 2023-02-02 | 2023-02-06 | 1,500,000 | — | $0 | 3,185,291 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-01 | 128,642 | $9.32 | $1.20M | 4,685,291 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-01-31 | 2023-02-01 | 185,000 | $9.25 | $1.71M | 4,813,933 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-01-30 | 2023-02-01 | 75,000 | $9.03 | $677.3K | 4,998,933 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-01-27 | 2023-01-31 | 50,000 | $9.02 | $451.0K | 5,073,933 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-01-25 | 2023-01-26 | 50,000 | $9.22 | $461.0K | 5,123,933 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-01-24 | 2023-01-26 | 100,000 | $9.27 | $927.0K | 5,173,933 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-01-23 | 2023-01-24 | 55,000 | $9.06 | $498.3K | 5,273,933 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-01-20 | 2023-01-24 | 100,000 | $9.15 | $915.0K | 5,328,933 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | J Other | 2022-12-13 | 2022-12-15 | 2,000,000 | — | $0 | 1,962,202 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | J Other | 2022-11-29 | 2022-12-01 | 2,000,000 | — | $0 | 1,839,160 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | J Other | 2022-09-20 | 2022-09-22 | 2,000,000 | — | $0 | 3,839,160 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2022-08-25 | 2022-08-26 | 200,000 | $6.22 | $1.24M | 5,428,933 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2022-08-24 | 2022-08-26 | 149,972 | $6.09 | $913.3K | 5,628,933 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2022-08-16 | 2022-08-18 | 128,456 | $6.04 | $775.9K | 5,778,905 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2022-08-15 | 2022-08-16 | 135,808 | $6.04 | $820.3K | 5,907,361 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2022-08-12 | 2022-08-16 | 348,007 | $6.12 | $2.13M | 6,043,169 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2022-06-08 | 2022-06-10 | 419,901 | $20.25 | $8.50M | 5,104,130 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-11-12 | 2021-11-16 | 1,900,000 | $8.38 | $15.92M | 1,148,780 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | J Other | 2021-11-10 | 2021-11-12 | 1,000,000 | — | $0 | 3,962,202 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | J Other | 2021-09-22 | 2021-09-24 | 1,000,000 | — | $0 | 4,962,202 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | J Other | 2021-05-06 | 2021-05-10 | 1,085,784 | — | $0 | 3,422,549 | SEC↗ |
| RVMD Revolution Medicines, Inc. | J Other | 2021-02-24 | 2021-02-26 | 1,500,000 | — | $0 | 5,524,031 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | J Other | 2021-02-04 | 2021-02-08 | 914,216 | — | $0 | 4,508,333 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-14 | 2021-01-14 | 1,965,294 | $41.00 | $80.58M | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 7,412 | $44.73 | $331.5K | 7,739,918 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 4,782 | $44.73 | $213.9K | 1,965,294 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 2,791 | $44.00 | $122.8K | 1,970,076 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 27,650 | $42.12 | $1.16M | 1,972,867 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 5,630 | $41.08 | $231.3K | 2,000,517 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 805,050 | $40.01 | $32.21M | 2,006,147 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 4,325 | $44.00 | $190.3K | 7,747,330 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 42,860 | $42.12 | $1.81M | 7,751,655 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 8,727 | $41.08 | $358.5K | 7,794,515 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-13 | 2021-01-14 | 1,247,873 | $40.01 | $49.93M | 7,803,242 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | S Sale | 2021-01-12 | 2021-01-14 | 1,500,000 | $40.00 | $60.00M | 9,051,115 | SEC↗ |
| RVMD Revolution Medicines, Inc. | J Other | 2020-12-02 | 2020-12-04 | 1,000,000 | — | $0 | 7,024,031 | SEC↗ |
| RVMD Revolution Medicines, Inc. | J Other | 2020-09-09 | 2020-09-11 | 1,000,000 | — | $0 | 8,024,031 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 39,216 | — | $0 | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 4,508,333 | — | $0 | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 875,000 | — | $0 | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 39,216 | — | $0 | 5,422,549 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 875,000 | — | $0 | 875,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 4,508,333 | — | $0 | 5,383,333 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 61,881 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 61,881 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 9,920,455 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 35,404,286 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 2,793,770 | — | $0 | 2,793,770 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 17,427 | — | $0 | 9,987,881 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 17,427 | — | $0 | 2,811,197 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 9,970,454 | — | $0 | 9,970,454 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 15,250,000 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 39,750,000 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 5,559,440 | — | $0 | 5,839,160 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 2,132,867 | — | $0 | 2,132,867 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 342,505 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 8,220,641 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 49,879 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 1,909,317 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion | 2020-02-18 | 2020-02-18 | 8,613,025 | — | $0 | 9,024,031 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion | 2020-02-18 | 2020-02-18 | 1,909,317 | — | $0 | 1,909,317 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | C Conversion deriv | 2019-07-22 | 2019-07-22 | 39,166,667 | — | $0 | 0 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | C Conversion deriv | 2019-07-22 | 2019-07-22 | 0 | — | $0 | 0 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | C Conversion | 2019-07-22 | 2019-07-22 | 5,595,238 | — | $0 | 5,880,952 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | P Buy | 2019-07-22 | 2019-07-22 | 81,250 | $16.00 | $1.30M | 5,962,202 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | J Other | 2018-09-19 | 2018-09-19 | 1,500,000 | — | $0 | 6,391,176 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion deriv | 2018-06-29 | 2018-07-03 | 1,708,185 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion deriv | 2018-06-29 | 2018-07-03 | 45,000,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion | 2018-06-29 | 2018-07-03 | 341,637 | — | $0 | 9,741,636 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | C Conversion | 2018-06-29 | 2018-07-03 | 8,999,999 | — | $0 | 9,399,999 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | J Other | 2018-06-20 | 2018-06-21 | 1,500,000 | — | $0 | 7,891,176 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2018-01-03 | 2018-01-05 | 816,326 | $42.00 | $34.29M | 680,272 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | J Other | 2017-04-12 | 2017-04-14 | 920,000 | — | $0 | 9,391,176 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 10,900 | $28.73 | $313.2K | 146,208 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 7,279 | $27.69 | $201.6K | 157,108 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 1,000,000 | $25.50 | $25.50M | 285,713 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 1,000,000 | $25.50 | $25.50M | 6,475,191 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 27,115 | $26.95 | $730.7K | 164,387 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion deriv | 2017-02-01 | 2017-02-03 | 11,250,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion deriv | 2017-02-01 | 2017-02-03 | 35,750,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion | 2017-02-01 | 2017-02-03 | 9,688,344 | — | $0 | 10,230,349 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion | 2017-02-01 | 2017-02-03 | 3,048,780 | — | $0 | 3,048,780 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | J Other | 2016-12-19 | 2016-12-21 | 750,000 | — | $0 | 10,311,176 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2016-11-14 | 2016-11-16 | 1,000,000 | $19.36 | $19.36M | 9,475,191 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2016-11-14 | 2016-11-16 | 1,000,000 | $19.36 | $19.36M | 1,285,713 | SEC↗ |
| EDIT Editas Medicine, Inc. | J Other | 2016-08-16 | 2016-08-16 | 750,000 | — | $0 | 3,906,176 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 222,222 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 6,628,542 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 5,255,300 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-08 | 4,656,176 | — | $0 | 4,656,176 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | C Conversion deriv | 2015-11-16 | 2015-11-18 | 45,000,000 | — | $0 | 0 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | C Conversion | 2015-11-16 | 2015-11-18 | 10,588,235 | — | $0 | 11,061,176 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion deriv | 2015-11-03 | 2015-11-05 | 5,500,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion deriv | 2015-11-03 | 2015-11-05 | 32,500,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion | 2015-11-03 | 2015-11-05 | 8,843,537 | — | $0 | 9,387,754 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion | 2015-11-03 | 2015-11-05 | 1,496,598 | — | $0 | 1,496,598 | SEC↗ |
| GBT Global Blood Therapeutics, | C Conversion deriv | 2015-08-17 | 2015-08-19 | 8,000,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | C Conversion | 2015-08-17 | 2015-08-19 | 2,285,713 | — | $0 | 2,285,713 | SEC↗ |